Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-01-15
2008-01-15
Mondesi, Robert B. (Department: 1652)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000, C536S023100
Reexamination Certificate
active
10474647
ABSTRACT:
The present invention relates to an anti-microbial polypeptide and a DNA construct encoding said anti-microbial polypeptide and the use of said anti-microbial polypeptide.
REFERENCES:
patent: WO 91/19738 (1991-12-01), None
patent: WO 94/01459 (1994-01-01), None
patent: WO 00/32220 (2000-06-01), None
Bowie, et al., Deciphering the message in the protein sequences: Tolerance to amino acid substitutions (1990) Science, vol. 247, pp. 1306-1310.
Rudinger, Peptide Hormones, University Park Press, 1976, Baltimore, MD., pp. 1-7.
Lee et al., Biochemical and Biophysical Research, vol. 263, pp. 646-651 (1999).
Martinez Ruiz et al., Biochemical and Biophysical, vol. 1340, pp. 81-87 (1998).
Tsang et al.,Aspergillus niger, ID BE759789 (2000).
Nakaya et al., Eur. J. Biochem, vol. 193, pp. 31-38 (1990).
Olivas et al., Biochemistry, vol. 34, pp. 3009-3021 (1995).
Wnendt et al., Nucleic Acids Research, vol. 18, No. 13, p. 3987 (1990).
Krenicky Michael W.
Mondesi Robert B.
Novozymes A/S
LandOfFree
Antimicrobial polypeptide from Aspergillus niger does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antimicrobial polypeptide from Aspergillus niger, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimicrobial polypeptide from Aspergillus niger will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3924005